Operating Expenses: The sum of all operating expenses for the given industry.
Cytokinetics, Incorporated (CYTK) had Operating Expenses of $196.12M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$17.75M |
|
$-183.03M |
|
-- |
|
$17.75M |
|
|
Operating Expenses |
$196.12M |
$-178.37M |
|
$-4.67M |
|
$-183.03M |
|
$-183.03M |
|
$-183.03M |
|
$-183.03M |
|
$-183.03M |
|
$-183.03M |
|
$-178.37M |
|
$-175.50M |
|
120.10M |
|
120.10M |
|
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$916.98M |
|
$79.19M |
|
$507.56M |
|
$1.42B |
|
$202.45M |
|
$1.12B |
|
$1.88B |
|
$2.08B |
|
$-659.62M |
|
$-659.63M |
|
$-659.62M |
|
122.94M |
|
| Cash Flow Statement Financials | |
$-510.01M |
|
$16.67M |
|
$524.46M |
|
$95.23M |
|
$125.63M |
|
$30.40M |
|
$112.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.53 |
|
-- |
|
-- |
|
2.45 |
|
-1.75 |
|
100.00% |
|
-1004.60% |
|
-1004.60% |
|
-- |
|
-1030.87% |
|
-1030.87% |
|
$-534.82M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.00 |
|
90.05 |
|
27.75% |
|
27.75% |
|
-12.85% |
|
-40.11% |
|
$-5.37 |
|
$-4.45 |
|
$-4.25 |
|